(Q33371085)

26 July 2017

title

Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure (English)

1 reference

26 July 2017

Paul Cockwell

4

0 references

Arthur R Bradwell

object named as

Arthur R Bradwell

8

0 references

author name string

Colin A Hutchison

1

1 reference

26 July 2017

Tim Plant

2

1 reference

26 July 2017

Mark Drayson

3

1 reference

26 July 2017

Melpomeni Kountouri

5

1 reference

26 July 2017

Kolitha Basnayake

6

1 reference

26 July 2017

Stephen Harding

7

1 reference

26 July 2017

Graham Mead

9

1 reference

26 July 2017

language of work or name

1 reference

22 September 2008

1 reference

26 July 2017

1 reference

26 July 2017

volume

9

1 reference

26 July 2017

page(s)

11

1 reference

Creative Commons Attribution 2.0 Generic

26 July 2017

copyright license

start time

22 September 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Serum free light chain (FLC) measurement can aid capillary zone electrophoresis in detecting subtle FLC-producing M proteins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Free immunoglobulin light-chain serum levels in the follow-up of patients with monoclonal gammopathies: correlation with 24-hr urinary light-chain excretion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Serum test for assessment of patients with Bence Jones myeloma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Long-term stability of albumin, protein HC, immunoglobulin G, kappa- and lambda-chain-immunoreactivity, orosomucoid and alpha 1-antitrypsin in urine stored at -20 degrees C.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Light chains of human immunoglobulins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Prognostic factors and effectiveness of treatment in acute renal failure due to multiple myeloma: a review of 50 cases. Report of the Italien Renal Immunopathology Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2564915

Presentation and survival of patients with severe renal failure and myeloma

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-9-11

Treatment of Renal Failure Associated With Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-9-11

Acute renal failure in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-9-11

Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-9-11

Renal Failure in Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-9-11

Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2369-9-11

Glomerular and proximal tubular morphology after single nephron obstruction

21 January 2018

1 reference

12 December 2020

Patients with multiple myeloma requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases

1 reference

12 December 2020

Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies

1 reference

12 December 2020

Multiple myeloma and renal failure: one center's experience

1 reference

12 December 2020

Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2369-9-11

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference